MACROGENICS INC — Director's Dealing 2013

Oct 9, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2013-10-09

Reporting Person: Wigginton Jon Marc (Senior V P, Clinical Dev.)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$4.69	2023-07-18	Common Stock (85225)		Direct
Stock Option (right to buy)	$4.69	2023-07-18	Common Stock (85225)		Direct

Footnotes

F1: 12.5% of the shares underlying the option are exercisable beginning on the six month anniversary of the vesting start date, and an additional 6.25% of the shares underlying the option become exercisable on the first day of each three month anniversary thereafter.

F2: Reflects a 1-for-18.7739 reverse split of our common stock effected on September 26, 2013.